Scott Megaffin, CEO of Adastra Pharmaceuticals, Inc., a company focused on the treatment of cancers with high unmet needs (such as high-grade gliomas), discusses positive top-line data from their Phase 1b clinical trial conducted by the National Cancer Institute evaluating zotiraciclib (ZTR/TG02) in combination with temozolomide (TMZ) in patients with recurrent high-grade gliomas, which have […]

Industry leaders and experts envisage positive change in the biopharma sector over the coming year, fueled by advances in science and data processing. The application of artificial intelligence will improve and make more efficient activities across the business continuum, from drug discovery to manufacturing, while genomics will offer even more fruitful avenues for the development […]

A drug is showing promising results in treating critical COVID-19 patients who are suffering from respiratory failure. Dr. Jonathan Javitt, the CEO Of NeuroRx, said they are encouraged by the results they’ve seen so far in the study of Zyesami. “So, we’re at the point we’ve got initial results from a 196-person study,” Javitt said […]